SMA is classified into different phenotypes (i.e., SMA type 0, type 1, type 2, type 3, and type 4) based on the age of onset as well as the severity of the clinical conditions, which is inversely related to the amount of SMN protein available at the motor neuron level [1]. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.